ABT-378/Ritonavir in Combination With Reverse Transcriptase Inhibitors in Antiretroviral Naïve HIV-Infected Subjects

Inclusion Criteria - HIV-1 positive - antiretroviral-adult males - non-pregnant - non-lactating females at least 18-years old with plasma HIV-1 RNA > 5000 copies/mL, who were not acutely ill Exclusion Criteria - History of: - prior antiretroviral therapy - significant drug hypersensitivity - psychiatric illness that precludes compliance - an active substance abuser - positive test results for drug abuse - abnormal lab test results (hemoglobin, absolute neutrophil count, platelet count, SGPT/AST or SGPT/ALT, creatinine, fasting triglycerides, significant abnormal ECG results - pregnancy or lactating female - received another investigational drug within 28 days of study initiation - unlikely to comply or unsuitable candidate in the opinion of the investigator